The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
Open accessAbstract
Adiponectin has recently been shown to be a promising candidate for the treatment of obesity-associated metabolic syndromes. Replenishment of recombinant adiponectin in mice can decrease hyperglycemia, reverse insulin resistance, and cause sustained weight loss without affecting food intake. Here we report its potential roles in alcoholic and nonalcoholic fatty liver diseases in mice. Circulating concentrations of adiponectin decreased significantly following chronic consumption of high-fat ethanol-containing food. Delivery of recombinant adiponectin into these mice dramatically alleviated hepatomegaly and steatosis (fatty liver) and also significantly attenuated inflammation and the elevated levels of serum alanine aminotransferase. These therapeutic effects resulted partly from the ability of adiponectin to increase carnitine palmitoyltransferase I activity and enhance hepatic fatty acid oxidation, while it decreased the activities of two key enzymes involved in fatty acid synthesis, including acetyl-CoA carboxylase and fatty acid synthase. Furthermore, adiponectin treatment could suppress the hepatic production of TNF-α and plasma concentrations of this proinflammatory cytokine. Adiponectin was also effective in ameliorating hepatomegaly, steatosis, and alanine aminotransferase abnormality associated with nonalcoholic obese, ob/ob mice. These results demonstrate a novel mechanism of adiponectin action and suggest a potential clinical application of adiponectin and its agonists in the treatment of liver diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adiponectin administration decreases IHTG (35), increases hepatic insulin sensitivity (36), and reverses obesity-related skeletal muscle insulin resistance (37).”
From Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) · cites this paper as [35]
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,261
Novel Modulator for Endothelial Adhesion Molecules
Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999) · Circulation · doi:10.1161/01.cir.100.25.2473 · Cited by 2,158
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. (2002) · Nature Medicine · doi:10.1038/nm724 · Cited by 2,114
Fruebis, J., Tsao, T., Javorschi, S., Ebbets-Reed, D., Erickson, M., Yen, F. T., Bihain, B. E., & Lodish, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.2005 · Cited by 2,007
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 998
Leptin Deficiency Contributes to the Pathogenesis of Alcoholic Fatty Liver Disease in Mice
Tan, X., Sun, X., Li, Q., Zhao, Y., Zhong, W. H., Sun, X., Jia, W. P., McClain, C. J., & Zhou, Z. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.06.013 · Cited by 57
Peroxisome proliferator-activated receptors: Bridging metabolic syndrome with molecular nutrition
Guri, A. J., Hontecillas, R., & Bassaganya-Riera, J. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.08.006 · Cited by 57
Weight-Loss Diets, Adiponectin, and Changes in Cardiometabolic Risk in the 2-Year POUNDS Lost Trial
Ma, W., Huang, T., Zheng, Y., Wang, M., Bray, G. A., Sacks, F. M., & Qi, L. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1207 · Cited by 59
Serum levels of hepatoprotective peptide adiponectin in non-alcoholic fatty liver disease
Aygün, C., Şentürk, Ö., Hülagü, S., Uraz, S., Çelebi, A., Konduk, B. T., Mutlu, B., & Cantürk, Z. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200602000-00010 · Cited by 57
Yokoyama, H., Hirose, H., Ohgo, H., & Saito, I. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.03.003 · Cited by 57
Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease
Iwaki, M., Kobayashi, T., Nogami, A., Saito, S., Nakajima, A., & Yoneda, M. (2023) · Nutrients · doi:10.3390/nu15040891 · Cited by 61
Insulin resistance in clinical and experimental alcoholic liver disease
Carr, R. M., & Correnti, J. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12787 · Cited by 57
Advances in Pediatric Nonalcoholic Fatty Liver Disease
Mencin, A., & Lavine, J. E. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2011.09.005 · Cited by 56
Shimizu, M., Tanaka, T., & Moriwaki, H. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0336-6 · Cited by 57
Inflammation, a link between obesity and atrial fibrillation
Scridon, A., Dobreanu, D., Chevalier, P., & Şerban, R. C. (2015) · Inflammation Research · doi:10.1007/s00011-015-0827-8 · Cited by 55
Ansari, R. A., Husain, K. M., & Rizvi, S. A. A. (2016) · Biomolecules · doi:10.3390/biom6030029 · Cited by 57
Similarities and Differences in the Pathogenesis of Alcoholic and Nonalcoholic Steatohepatitis
Syn, W., Teaberry, V. S., Choi, S. S., & Diehl, A. M. (2009) · Seminars in Liver Disease · doi:10.1055/s-0029-1214375 · Cited by 56
Wang, A. Y.-H., Hickman, I. J., Richards, A. A., Whitehead, J. P., Prins, J. B., & Macdonald, G. A. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00311.x · Cited by 55
Mohamadkhani, A., Sayehmiri, K., Ghanbari, R., Elahi, E., Poustchi, H., & Montazeri, G. (2010) · Virology Journal · doi:10.1186/1743-422x-7-228 · Cited by 55
Azevedo, V. Z., Silaghi, C. A., Maurel, T., Silaghi, H., Ratziu, V., & Pais, R. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.774030 · Cited by 59
de Oliveira, A. C., Andreotti, S., de Farias, T. D. S. M., Torres‐Leal, F. L., de Proença, A. R. G., Campaña, A. B., de Souza, A. H., Sertié, R. A. L., Carpinelli, Â. R., Cipolla‐Neto, J., et al. (2012) · Endocrinology · doi:10.1210/en.2011-1675 · Cited by 55
Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
Huang, Y. Y., Gusdon, A. M., & Qu, S. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-171 · Cited by 55
Polyzos, S. A., Kountouras, J., & Zavos, C. (2009) · Europe PMC (PubMed Central) · Cited by 55
Matsunami, T., Sato, Y., Ariga, S., Sato, T., Kashimura, H., Hasegawa, Y., & Yukawa, M. (2010) · PubMed Central · Cited by 53
Molecular Mechanisms of Hepatic Fibrosis in Non-Alcoholic Steatohepatitis
Rombouts, K., & Marra, F. (2010) · Digestive Diseases · doi:10.1159/000282094 · Cited by 54
Tam, J., Godlewski, G., Earley, B. J., Zhou, L., Jourdan, T., Szanda, G., Çınar, R., & Kunos, G. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00489.2013 · Cited by 56
Frederico, M. J. S., Vitto, M. F., Cesconetto, P. A., Engelmann, J., de Souza, D. R., da Luz, G., Pinho, R. A., Ropelle, E. R., Cintra, D. E., & de Souza, C. T. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.613945 · Cited by 55
Metaflammatory responses during obesity: Pathomechanism and treatment
Debnath, M., Agrawal, S., Agrawal, A., & Dubey, G. P. (2015) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2015.10.012 · Cited by 58
Mancinelli, A. C., Veroli, A. D., Mattioli, S., Cruciani, G., Bosco, A. D., & Castellini, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-05986-2 · Cited by 54
Molecular mechanism of crosstalk between immune and metabolic systems in metabolic syndrome
Hachiya, R., Tanaka, M., Itoh, M., & Suganami, T. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00198-7 · Cited by 56
Anti-Obesity Effect of Artemisia capillaris Extracts in High-Fat Diet-Induced Obese Rats
Lim, D., Kim, Y. T., Jang, Y.-J., Kim, Y.-E., & Han, D. (2013) · Molecules · doi:10.3390/molecules18089241 · Cited by 53
The role of cytokines in non-alcoholic steatohepatitis. A review.
Copaci, I., Micu, L., & Voiculescu, M. (2006) · PubMed · Cited by 53
de Oliveira, M. C., Gilglioni, E. H., de Boer, B. A., Runge, J. H., de Waart, D. R., Salgueiro, C. L., Ishii‐Iwamoto, E. L., Elferink, R. P. J. O., & Gaemers, I. C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.012 · Cited by 53
Cederquist, C., Lentucci, C., Calejman, C. M., Hayashi, V., Orofino, J., Guertin, D. A., Fried, S. K., Lee, M., Cardamone, M. D., & Perissi, V. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.10.007 · Cited by 53
Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas
Liu, Y.-C. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i14.2161 · Cited by 53
Nannipieri, M., Cecchetti, F., Anselmino, M., Mancini, E., Marchetti, G., Bonotti, A., Baldi, S., Solito, B., Giannetti, M., Pinchera, A., et al. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9701-x · Cited by 53
Wang, Y., Xu, L. Y., Lam, K. S. L., Lü, G., Cooper, G. J. S., & Xu, A. (2006) · PROTEOMICS · doi:10.1002/pmic.200500840 · Cited by 53
Self-citationHiguchi, A., Ohashi, K., Shibata, R., Sono-Romanelli, S., Walsh, K. X., & Ouchi, N. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.198465 · Cited by 52
Association of Coronary Artery Calcification With Hepatic Steatosis in Asymptomatic Individuals
Chhabra, R., O’Keefe, J. H., Patil, H., O’Keefe, E. L., Thompson, R. C., Ansari, S., Kennedy, K. F., Lee, L. W., & Helzberg, J. H. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.06.025 · Cited by 52
Terakura, D., Shimizu, M., Iwasa, J., Baba, A., Kochi, T., Ohno, T., Kubota, M., Shirakami, Y., Shiraki, M., Takai, K., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs303 · Cited by 52
Suzawa, M., Miranda, D. A., Ramos, K. A., Ang, K. K.-H., Faivre, E. J., Wilson, C. G. M., Caboni, L., Arkin, M. R., Kim, Y.-S., Fletterick, R. J., et al. (2015) · eLife · doi:10.7554/elife.09003 · Cited by 52
Potential role ofHelicobacter pyloriinfection in nonalcoholic fatty liver disease
Li, M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i41.7024 · Cited by 51
The potential role of genes in nonalcoholic fatty liver disease
Day, C. P. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.001 · Cited by 51
Sphingolipids and Hepatic Steatosis
Bikman, B. T., & Summers, S. A. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0650-1_6 · Cited by 51
Some novel insights into the pathogenesis of alcoholic steatosis
Lakshman, M. (2004) · Alcohol · doi:10.1016/j.alcohol.2004.08.004 · Cited by 50
Schattenberg, J. M., & Schuchmann, M. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0366-2 · Cited by 49
Influence of Sleeve Gastrectomy on NASH and Type 2 Diabetes Mellitus
Karcz, W. K., Krawczykowski, D. R., Kuesters, S., Marjanović, G., Kulemann, B., Gröbe, H., Karcz-Socha, I., Hopt, U. T., Bukhari, W., & Grueneberger, J. M. (2010) · Journal of Obesity · doi:10.1155/2011/765473 · Cited by 50
Mahmoud, M. F., El-Swefy, S. E., Hasan, R. A., & Ibrahim, A. A. E.-M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.08.021 · Cited by 50
Zografos, T. A., Liaskos, C., Rigopoulou, E. I., Togousidis, E., Makaritsis, K. P., Germenis, A. E., & Dalekos, G. Ν. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01729.x · Cited by 49
Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas
Liu, Y., Shen, C., Wu, H., Hsieh, T., Chan, D., Chen, C., Yu, J., Yu, C., Harn, H., Chen, P., et al. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i14.2168 · Cited by 50
Emerging and future therapies for nonalcoholic steatohepatitis in adults
Mintziori, G., & Pοlyzos, S. A. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1225727 · Cited by 50
Function and Dysfunction of Adipose Tissue
Matafome, P. N., & Seiça, R. M. F. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-63260-5_1 · Cited by 51
Antwi, S. O., Mousa, O. Y. S., & Patel, T. C. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0010.8659 · Cited by 50
Song, B., Akbar, M. D., Jo, I., Hardwick, J. P., & Abdelmegeed, M. A. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2015.04.002 · Cited by 51
Effect of alcohol on adipose tissue: a review on ethanol mediated adipose tissue injury
Kema, V. H., Mojerla, N. R., Khan, I., & Mandal, P. (2015) · Adipocyte · doi:10.1080/21623945.2015.1017170 · Cited by 50
Hepatic lipase activity is increased in non‐alcoholic fatty liver disease beyond insulin resistance
Miksztowicz, V., Lucero, D., Zago, V., Cacciagiú, L. D., López, G., Ballerga, E. G., Sorda, J. A., Fassio, E., Schreier, L. E., & Berg, G. A. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2312 · Cited by 49
Physiological significance of heme oxygenase in hypertension
Cao, J. J., Inoue, K., Li, X., Drummond, G., & Abraham, N. G. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.10.025 · Cited by 49
Serum Adipokine and Ghrelin Levels in Nonalcoholic Steatohepatitis
Yalnız, M., Bahçecioğlu, İ. H., Ataseven, H., Üstündağ, B., İlhan, F., Poyrazoğlu, O. K., & Erensoy, A. (2006) · Mediators of Inflammation · doi:10.1155/mi/2006/34295 · Cited by 49
The Restorative Effect of Taurine on Experimental Nonalcoholic Steatohepatitis
Chen, S., Chen, Y.-X., Shi, J. G., Lin, Y., & Xie, W. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9359-y · Cited by 49
Bykov, I., Jauhiainen, M., Olkkonen, V. M., Saarikoski, S. T., Ehnholm, C., Junnikkala, S., Väkevä, A., Lindros, K. O., & Meri, S. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.11.020 · Cited by 49
Adipose tissue deletion of Gpr116 impairs insulin sensitivity through modulation of adipose function
Nie, T., Hui, X. H., Gao, X., Li, K., Lin, W., Xiang, X., Ding, M., Kuang, Y., Xu, A., Fei, J., et al. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.08.006 · Cited by 49
Self-citationKalafateli, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i10.3020 · Cited by 50
Dou, X., Xia, Y., Chen, J., Qian, Y., Li, S., Zhang, X., & Song, Z. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12765 · Cited by 50
Non-alcoholic fatty liver disease: From insulin resistance to mitochondrial dysfunction
Herruzo, J. A. S., Ruiz, I. G., Carreras, M. P., & Muñoz-Yagüe, M. T. (2006) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082006001100006 · Cited by 48
Richards, A. A., Colgrave, M. L., Zhang, J., Webster, J. A., Simpson, F., Preston, E., Wilks, D. L., Hoehn, K. L., Stephenson, M., Macdonald, G. A., et al. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0133 · Cited by 49
Self-citationRole of Adiponectin and Inflammation in Insulin Resistance of Mc3r and Mc4r Knockout Mice
Trevaskis, J. L., Gawrońska‐Kozak, B., Sutton, G. M., McNeil, M., Stephens, J. M., Smith, S. R., & Butler, A. A. (2007) · Obesity · doi:10.1038/oby.2007.318 · Cited by 50
Shimizu, M., Yasuda, Y., Sakai, H., Kubota, M., Terakura, D., Baba, A., Ohno, T., Kochi, T., Tsurumi, H., Tanaka, T., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-281 · Cited by 48
Clinical implications of understanding the association between oxidative stress and pediatric NAFLD
Mann, J. P., Raponi, M., & Nobili, V. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1291340 · Cited by 48
Stefan, N., Machann, J., Schick, F., Claussen, C. D., Thamer, C., Fritsche, A., & Häring, H. (2005) · Hormone Research in Paediatrics · doi:10.1159/000089316 · Cited by 48
Kücükoglu, Ö., Güldiken, N., Chen, Y., Usachov, V., Heliebi, A. E., Haybaeck, J., Denk, H., Trautwein, C., & Strnad, P. (2014) · Hepatology · doi:10.1002/hep.27068 · Cited by 47
Liver fibrogenesis and metabolic factors
Anty, R., & Lemoine, M. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/s2210-7401(11)70003-1 · Cited by 47
Xiao, X., Li, H., Qi, X., Wang, Y., Xu, C., Liu, G., Wen, G., & Liu, J. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.06.003 · Cited by 47
Self-citationAn overview of energy and metabolic regulation
Wen, S., Wang, C., Gong, M., & Zhou, L. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9371-4 · Cited by 53
Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosis
Neumeier, M. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i34.5490 · Cited by 47
Leung, K., Xu, A., Craig, M. E., Martin, A. M., Lam, K. S. L., & O’Sullivan, A. (2009) · Metabolism · doi:10.1016/j.metabol.2008.09.020 · Cited by 47
Self-citation(2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.012 · Cited by 46
Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development
Jiang, C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16464 · Cited by 49
Endocrine Diseases and the Liver
Maheshwari, A., & Thuluvath, P. J. (2010) · Clinics in Liver Disease · doi:10.1016/j.cld.2010.09.008 · Cited by 46
Adipokine signaling in inflammatory bowel disease
Batra, A., Zeitz, M., & Siegmund, B. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20937 · Cited by 46
Geng, T., Yang, B., Li, F., Xia, L., Wang, Q., Zhao, X., & Gong, D. (2016) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2016.01.006 · Cited by 46
Lin, Y., Tai, S.-Y., Chen, J., Chou, C., Fu, S., & Chen, Y. (2017) · Food & Function · doi:10.1039/c7fo00123a · Cited by 46
Dou, X., Li, S., Hu, L., Ding, L., Ma, Y., Ma, W., Chai, H., & Song, Z. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-017-0013-x · Cited by 46
Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors
Neumeier, M., Weigert, J., Schäffler, A., Weiß, T. S., Kirchner, S., Laberer, S., Schölmerich, J., & Buechler, C. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.187 · Cited by 46
Qin, Y., & Tian, Y. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-78 · Cited by 45
AMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability
Yang, Y. M. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i30.3731 · Cited by 46
Jichitu, A., BUNGAU, S. G., Stănescu, A. M. A., Vesa, C. M., Toma, M. M., Bustea, C., Iurciuc, S., Rus, M., Bacalbaşa, N., & Diaconu, C. C. (2021) · Diagnostics · doi:10.3390/diagnostics11040689 · Cited by 47
Genetic variants in candidate genes influencing NAFLD progression
Rosa, M. D., & Malaguarnera, L. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0803-x · Cited by 47
Adiponectin as a protective factor in hepatic steatosis
Méndez-Sánchez, N. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i12.1737 · Cited by 45
Liver and Muscle in Morbid Obesity: The Interplay of Fatty Liver and Insulin Resistance
Machado, M. V., Ferreira, D. M. S., Castro, R. E., Silvestre, A. R., Evangelista, T., Coutinho, J., Carepa, F., Costa, A., Rodrigues, C. M. P., & Cortez‐Pinto, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031738 · Cited by 49
Pai, W.-Y., Hsu, C.-C., Lai, C., Chang, T.-Z., Tsai, Y., & Her, G. M. (2013) · Transgenic Research · doi:10.1007/s11248-012-9685-0 · Cited by 46
Li, Z., Xu, J., Zheng, P., Xing, L., Shen, H., Yang, L., Zhang, L. R., & Ji, G. (2015) · PubMed Central · Cited by 44
Lee, H.-I., & Lee, M. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.06.016 · Cited by 44
Wanninger, J., Neumeier, M., Hellerbrand, C., Schacherer, D., Bauer, S., Weiß, T. S., Huber, H., Schäffler, A., Aslanidis, C., Schölmerich, J., et al. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.11.001 · Cited by 44
Buemann, B., Astrup, A. V., Pedersen, O. B., Black, E., Holst, J. J., Toubro, S., Echwald, S. M., Holst, J. J., Rasmussen, C., & Sørensen, T. I. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1062 · Cited by 43
Khanal, T., Choi, J. H., Hwang, Y. P., Chung, Y., & Jeong, H. G. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.08.006 · Cited by 44
Park, P.-H., Huang, H., McMullen, M. R., Bryan, K., & Nagy, L. E. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907631 · Cited by 53
New Insights from Rodent Models of Fatty Liver Disease
Maher, J. J. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3749 · Cited by 43
Konuma, K., Itoh, M., Suganami, T., Kanai, S., Nakagawa, N., Sakai, T., Kawano, H., Hara, M., Kojima, S., Izumi, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121528 · Cited by 43
Regulation of adiponectin receptor expression in human liver and a hepatocyte cell line
Shimizu, A., Takamura, T., Matsuzawa, N., Nakamura, S., Nabemoto, S., Takeshita, Y., Misu, H., Kurita, S., Sakurai, M., Yokoyama, M., et al. (2007) · Metabolism · doi:10.1016/j.metabol.2007.06.013 · Cited by 43
Bile acids and insulin resistance: implications for treating nonalcoholic fatty liver disease
Wei, J., Qiu, D., & Ma, X. (2009) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2009.00369.x · Cited by 43
Protective effects of p-coumaric acid against high-fat diet-induced metabolic dysregulation in mice
Yoon, D. S., Cho, S. Y., Yoon, H. J., Kim, S. R., & Jung, U. J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111969 · Cited by 46
Bora, P. S., Kaliappan, S., Lyzogubov, V. V., Tytarenko, R. G., Thotakura, S., Viswanathan, T., & Bora, N. S. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.024 · Cited by 44
Yun, J.-W., Kim, Y. K., Lee, B., Kim, C.-W., Hyun, J.-S., Baik, J.-H., Kim, J., & Kim, B.-H. (2007) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.70403 · Cited by 43
The Association Between Hepatic Fat Content and Liver Injury in Obese Children and Adolescents
Santoro, N., Feldstein, A. E., Enoksson, E., Pierpont, B. M., Kursawe, R., Kim, G., & Caprio, S. (2012) · Diabetes Care · doi:10.2337/dc12-1791 · Cited by 42
Guerra, J. F. D. C., Maciel, P. S., de Abreu, I. C. M. E., Pereira, R. R., Silva, M., Cardoso, L. D. M., Pinheiro-Sant’Ana, H. M., de Lima, W. G., Silva, M. E., & Pedrosa, M. L. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.01.025 · Cited by 43
Metadata
- Authors
- Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S.
- Affiliations
- University of Auckland (NZ)
- University of Hong Kong (HK)
- Corresponding author
- Xu, Aimin
- Venue
- Journal of Clinical Investigation
- Published
- 2003-07-01
- Volume
- 112
- Issue
- 1
- Pages
- 91-100
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC162288
- OpenAlex
- W2120590109
- Cited by
- 1,298
- References
- 68
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 29 · 2023: 34 · 2022: 34 · 2021: 43 · 2020: 38 · 2019: 35 · 2018: 54 · 2017: 50 · 2016: 50 · 2015: 69 · 2014: 75 · 2013: 59 · 2012: 68
- FWCI
- 49.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- Auckland Medical Research Foundation
- University of Hong Kong
- Health Research Council of New Zealand
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- adiponectin, alcoholic fatty liver, non-alcoholic fatty liver disease, hepatic steatosis, hepatomegaly, liver inflammation, TNF-α, carnitine palmitoyltransferase 1, hepatic fatty acid oxidation, fatty acid synthesis, acetyl-CoA carboxylase, fatty acid synthase, alanine aminotransferase, ob/ob mice, obesity
- MeSH terms
- Alanine Transaminase, Animals, Fatty Acids, Fatty Liver, Fatty Liver, Alcoholic, Liver, Male, Mice, Inbred C57BL, Obesity, Morbid, Oxidation-Reduction, Proteins, Recombinant Proteins, Tumor Necrosis Factor-alpha, Intercellular Signaling Peptides and Proteins, Mice, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review